COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #126
Source   Share   Tweet
See all 182 studies
Early treatment study
Sulaiman et al., medRxiv, doi:10.1101/2020.09.09.20184143 (Preprint)
The Effect of Early Hydroxych loroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study
Observational prospective 5,541 patients, adjusted HC Q mortality odds ratio OR 0.36, p = 0.012. Adjusted hospitalization OR 0.57, p < 0.001. Zinc supplementation was used in all cases. Early treatment in ambulatory fever clinics in Saudi Arabia.
death, ↓63.7%, p=0.01
hospitalization, ↓38.6%, p=0.001
(odds ratio converted to relative risk)
Source   Share   Tweet
See all 182 studies
Please send us corrections, updates, or comments.